L
Lophos Holdings Inc. Stock Analysis MESC.CN
Lophos Holdings, Inc. engages in the research and development of compounds derived from peyote cactus. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2023-09-06. The firm is also engaged in the research and development of compounds derived from the peyote cactus. Its cultivated peyote cactus will be used by the Company to conduct pre-clinical research and development in Canada either directly through a Controlled Substance Dealers License (CSDL) at its Napanee facility, or indirectly with one or more third-party partners. Its CSDL licensing includes the development of intellectual property related to the chemical composition of peyote and the custom formulation of Mescaline and related compounds and the research and development of drug delivery systems for Mescaline and other related molecules. The company also operates a Health Canada licensed analytical testing and research and development institution, to conduct pre-clinical research and development.
Read More Lophos Holdings Inc (MESC.CN) Chart
Key Statistics of Lophos Holdings Inc (MESC.CN)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
CAD0.01Volume
140.00KP/E Ratio (TTM)
-Market Cap
860.00KAvg. Volume
432.51KDividend Yield
-Financial Metrics & Statements of Lophos Holdings Inc (MESC.CN)
FAQ's for Lophos Holdings Inc (MESC.CN)
- According to Musaffa’s Shariah screening methodology, Lophos Holdings Inc (MESC.CN) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.